Jiannan Xu
-
- Lung Cancer Diagnosis and Treatment 3
- Ferroptosis and cancer prognosis 2
-
- Cancer-related molecular mechanisms research 4
-
- Cancer Immunotherapy and Biomarkers 2
- Inflammatory Biomarkers in Disease Prognosis 2
-
- RNA modifications and cancer 4
-
- Genetic factors in colorectal cancer 3
-
- Immune cells in cancer 2
- Journals
- Scientific Reports (1 paper)Biochemical and Biophysical Research Communications (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Jiannan Xu
19 papers receiving 178 citations
Peers
Comparison fields: 5 of 58
- Anesthesiology and Pain Medicine 22
- Nephrology 14
- Pulmonary and Respiratory Medicine 64
- Cancer Research 25
- Oncology 44
Countries citing papers authored by Jiannan Xu
This map shows the geographic impact of Jiannan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiannan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiannan Xu more than expected).
Fields of papers citing papers by Jiannan Xu
This network shows the impact of papers produced by Jiannan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiannan Xu. The network helps show where Jiannan Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiannan Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 0 | |
| 10 | 2022 | 1 | |
| 11 | 2022 | 30 | |
| 12 | 2022 | 4 | |
| 13 | 2022 | 18 | |
| 14 | 2021 | 17 | |
| 15 | 2021 | 20 | |
| 16 | 2021 | 9 | |
| 17 | 2019 | 1 | |
| 18 | 2019 | 38 | |
| 19 | 2016 | 13 | |
| 20 | 2015 | 15 |
About Jiannan Xu
Jiannan Xu is a scholar working on Cancer Research, Oncology and Otorhinolaryngology, having authored 22 papers that have together received 184 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers), Genetic factors in colorectal cancer (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Ferroptosis and cancer prognosis (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Anesthesiology and Pain Medicine (22 citations), Nephrology (14 citations) and Pulmonary and Respiratory Medicine (64 citations). Jiannan Xu has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Yulong He, Junchang Zhang, Changhua Zhang, Yan Zhang, Huiguo Chen, Kai Zhang, Weibin Wu, Xiaojun Li, Jian Zhang and Yuan Cheng. Their work appears in journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.